There is a strong argument to combine adoptively transferred allogeneic CD38-KO NK cells with anti-CD38 antibodies, potentially in combination with strategies to induce CD38 expression on MM cells, thus overcome potential resistance to anti-CD38 antibodies [91]. This evidence concerns the gene CD38 and Miyoshi myopathy.